• Home Study Details

  • Home / Learn / Home Study CE / Home Study Details


Another Broken Heart - Understanding and Treating Heart Failure

Program Type

OnDemand

Credits

1 Contact Hour(s)

Release Date

Monday, October 15, 2018

Offline Date:

Monday, April 15, 2019

ACPE Expiration Date

Friday, August 27, 2021

Target Audience

Nurse, Pharmacist

Cost

$0.00

  • Overview

    More than 10 million patients visit their physician every year for heart failure. More patients require hospitalization for heart failure than all types of cancer combined. Heart failure usually gets worse with time and approximately 50% of patients with heart failure die within 5 years. Pharmacist involvement in the management of chronic heart failure can improve quality of life and minimize hospitalization. This knowledge-based activity will review the recommendations and updated pharmacotherapy for heart failure to include appropriate candidates, relevant drug interactions and monitoring parameters. Further, the activity will offer pharmacists strategies for educating patients on treatment and encouraging compliance with drug and diet therapy as part of the health care team to reduce further hospitalizations and improve patient outcomes.

    Rating


    Handouts

    Slide Document:   18111H01_4pp.pdf
    Slide Document:   18111H01_2pp.pdf

    Financial Support By

    Novartis
  • Nurse

    Outline the key changes/recommendations identified in the 2017 ACCF/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guidelines for the Management of Heart Failure.
    Describe the current and emerging pharmacotherapies for patients with heart failure with reduced ejection fraction (HFrEF) to include their role in therapy, adverse events, safety concerns, and key counseling points associated with each.
    Identify the pharmacist’s role in educating patients on the importance of HF prevention, hypertension management, and the treatment of comorbid conditions related to managing heart failure.


    Pharmacist

    Outline the key changes/recommendations identified in the 2017 ACCF/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guidelines for the Management of Heart Failure.
    Describe the current and emerging pharmacotherapies for patients with heart failure with reduced ejection fraction (HFrEF) to include their role in therapy, adverse events, safety concerns, and key counseling points associated with each.
    Identify the pharmacist’s role in educating patients on the importance of HF prevention, hypertension management, and the treatment of comorbid conditions related to managing heart failure.

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-0000-18-111-H01-P

    Pharmacist 0798-0000-18-111-H01-P

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

 

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.